Milestones - pick a card....any card.Unless Howard pulls another we can't control the process or timelines and lawyers are slow act again here is what they have put out there to achieve by end of July...
- Finalize due diligence and agree on terms with new organization in China
-Complete an additional licensing agreement for the SGLT2 inhibitor in new markets
- Secure non-dilutive funding through anticipated collaborations
- Finalize Tinyi agreement
- Complete Phase I clinical trial in China for the SGLT2 Inhibitor and advance to Phase II
Now you would think that SBM would have gotten a release date from Wanbang otherwise they wouldn't have it included it in the checklist. So of all the milestones I think this one should be completed since it has already been 7 years and is overdue to start with and Wanbang likely gave SBM the timeframe the Phase I results would be ready for public consumption.
I'd love to see them wrap up the animal use contract too since it is with 2 international companies and I get the impression they've split up the global rights so should be fairly substantial dollar value attached to it. But for heavens sake just finalize something cause it is getting absurd the lack of news and contracts given the time periods they've had to execute on these.